Chondroitin sulfate in osteoarthritis treatment in patients with comorbid cardiovascular diseases: hypertension, atherosclerosis, coronary heart disease
Osteoarthritis (OA) is the most common joint disease globally, and its incidence increases with age – up to 80–90% in people over 60 years. There is a high comorbidity between OA and cardiovascular diseases (CVD), such as arterial hypertension (AH), atherosclerosis, and coronary heart disease (CHD)....
Saved in:
| Main Authors: | O. A. Shavlovskaya, I. A. Bokova, I. V. Sarvilina, N. I. Shavlovskiy, Yu. D. Yukhnovskaya |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
IMA-PRESS LLC
2021-06-01
|
| Series: | Неврология, нейропсихиатрия, психосоматика |
| Subjects: | |
| Online Access: | https://nnp.ima-press.net/nnp/article/view/1586 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Structum (chondroitin sulfate) in treatment of osteoarthritis
by: O J Varga, et al.
Published: (2003-02-01) -
Disease-modifying osteoarthritis drugs (DMOADs): new trends in osteoarthritis therapy
by: O. A. Shavlovskaya, et al.
Published: (2023-11-01) -
Pharmacotherapy of pain in musculoskeletal diseases: evolution and revolution of views
by: O. A. Shavlovskaya, et al.
Published: (2022-08-01) -
Study of efficiency of chondroitin-sulfate parenteral preparation in the therapy of recurrent chronic pain under osteoarthritis of knee-joints in comorbid patients
by: A. S. Sycheva, et al.
Published: (2021-06-01) -
Research progress of chondroitin sulfate and chondroitin sulfate proteoglycan in diabetic kidney disease
by: ZHANG Min, et al.
Published: (2019-01-01)